FDA Releases Spring 2024 Unified Agenda, Focuses on Clinical Studies, Misinformation, Plans Culture Change for Pediatric Drugs

FDA leaders vow to change agency culture to smooth path for pediatric drugs https://t.co/RmAjeTsfBU

FDA Revisits and Updates Guidance on Addressing Misinformation – Ten Years Later https://t.co/81EQMIxqdJ | by @SheppardMullin

In a new revised draft guidance document, the FDA says it will allow life sciences companies to address misinformation about their products that is posted online. Read our analysis here: https://t.co/VzIx3nDEci #AgencyIQ #Politico #LifeSciences #Regulation #FDA #Regulatory https://t.co/Ro2VKM1iSQ